Rare diseases
Investigational molecules
Locations
Boulevard De La Chantourne, Cs 10217, La Tronche, 38043 Grenoble, France
Centre Hospitalier Universitaire Grenoble Alpes in Grenoble, France specialises in clinical trials of conditions such as Non-small cell lung cancer, Hepatocellular carcinoma, Chronic obstructive pulmonary disease, Acute myeloid leukaemia, and other specialisations. This site conducts important research.
Clinical trials currently enrolling participants at this site.
Phase 3 Study of Pitolisant for Excessive Daytime Sleepiness in Narcolepsy Patients
FranceRandomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease
FrancePhase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
FranceOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
FranceA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
FranceA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
FranceA study of navenibart for long-term safety in patients with hereditary angioedema
FranceA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
FranceA study testing duvakitug for patients with moderately to severely active ulcerative colitis
FranceStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
FranceStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
FranceStudy of PF-07328948 tablets compared to placebo in adults with heart failure to evaluate effects on symptoms and physical function
FranceGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
